UBS Group’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-105,315
| Closed | -$2.05M | – | 7415 |
|
|
2018
Q1 | $2.05M | Sell |
105,315
-3,444
| -3% | -$67K | ﹤0.01% | 2535 |
|
|
2017
Q4 | $1.81M | Buy |
108,759
+29,497
| +37% | +$491K | ﹤0.01% | 2592 |
|
|
2017
Q3 | $1.61M | Buy |
79,262
+38,411
| +94% | +$780K | ﹤0.01% | 2654 |
|
|
2017
Q2 | $658K | Buy |
40,851
+10,210
| +33% | +$164K | ﹤0.01% | 3182 |
|
|
2017
Q1 | $387K | Sell |
30,641
-14,726
| -32% | -$186K | ﹤0.01% | 3446 |
|
|
2016
Q4 | $601K | Sell |
45,367
-32,937
| -42% | -$436K | ﹤0.01% | 3180 |
|
|
2016
Q3 | $1.86M | Buy |
78,304
+42,850
| +121% | +$1.02M | ﹤0.01% | 2287 |
|
|
2016
Q2 | $1.02M | Sell |
35,454
-2,973
| -8% | -$85.7K | ﹤0.01% | 2683 |
|
|
2016
Q1 | $1.23M | Buy |
38,427
+742
| +2% | +$23.8K | ﹤0.01% | 2510 |
|
|
2015
Q4 | $1.61M | Buy |
37,685
+30,209
| +404% | +$1.29M | ﹤0.01% | 2356 |
|
|
2015
Q3 | $263K | Sell |
7,476
-20,514
| -73% | -$722K | ﹤0.01% | 3533 |
|
|
2015
Q2 | $1.29M | Buy |
27,990
+11,151
| +66% | +$512K | ﹤0.01% | 2631 |
|
|
2015
Q1 | $789K | Sell |
16,839
-113,142
| -87% | -$5.3M | ﹤0.01% | 2942 |
|
|
2014
Q4 | $4.12M | Buy |
+129,981
| New | +$4.12M | ﹤0.01% | 1742 |
|